Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs

Ronald P. van Rij, Janny A. Visser, Rieneke M. E. van Praag, Ronald Rientsma, Jan M. Prins, Joep M. A. Lange, Hanneke Schuitemaker

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)

Abstract

A viral reservoir of human immunodeficiency virus type 1 (HIV-1)-infected, resting CD4(+) T cells persists despite suppression of plasma viremia by combination antiretroviral therapy. In a longitudinal analysis of three patients treated with a five-drug regimen, both R5 and X4 HIV-1 variants persisted in the cellular reservoir for up to 3 years
Original languageEnglish
Pages (from-to)3054-3058
JournalJournal of Virology
Volume76
Issue number6
DOIs
Publication statusPublished - 2002

Cite this